| 389 |
Corticosteroid, a double-edged sword in inflammatory bowel disease management: possibility of reducing corticosteroid use through physician educationCorticosteroid, a double-edged sword in inflammatory bowel disease management: possibility of reducing corticosteroid use through physician education
Seulji Kim, Seong-Joon KohSeulji Kim, Seong-Joon Koh
KMSID: 1516081561 Intest Res. 2022;20(4):389-391. Published online 2022 October 28 DOI: http://dx.doi.org/10.5217/ir.2022.00117 |
|
| 392 |
Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapiesInvolvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies
Priscila A. Lima, Bárbara B. Berg, Marina Gomes Miranda e CastorPriscila A. Lima, Bárbara B. Berg, Marina Gomes Miranda e Castor
KMSID: 1516081557 Intest Res. 2022;20(4):392-417. Published online 2022 May 31 DOI: http://dx.doi.org/10.5217/ir.2021.00160 |
|
| 418 |
Natural history of inflammatory bowel disease: a comparison between the East and the WestNatural history of inflammatory bowel disease: a comparison between the East and the West
Eun Mi Song, Suk-Kyun YangEun Mi Song, Suk-Kyun Yang
KMSID: 1516081553 Intest Res. 2022;20(4):418-430. Published online 2021 December 2 DOI: http://dx.doi.org/10.5217/ir.2021.00104 |
|
| 431 |
Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statementsKorean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements
Yong Eun Park, Yoo Jin Lee, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seong-Eun Kim, Seung-Jae MyungYong Eun Park, Yoo Jin Lee, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seong-Eun Kim, Seung-Jae Myung
KMSID: 1516081554 Intest Res. 2022;20(4):431-444. Published online 2022 January 5 DOI: http://dx.doi.org/10.5217/ir.2021.00111 |
|
| 445 |
Efficacy of hepatitis B vaccination in patients with ulcerative colitis: a prospective cohort studyEfficacy of hepatitis B vaccination in patients with ulcerative colitis: a prospective cohort study
Anurag Mishra, Amarender Singh Puri, Sanjeev Sachdeva, Ashok DalalAnurag Mishra, Amarender Singh Puri, Sanjeev Sachdeva, Ashok Dalal
KMSID: 1516081551 Intest Res. 2022;20(4):445-451. Published online 2022 February 8 DOI: http://dx.doi.org/10.5217/ir.2021.00106 |
|
| 452 |
Physician education can minimize inappropriate steroid use in patients with inflammatory bowel disease: the ACTION studyPhysician education can minimize inappropriate steroid use in patients with inflammatory bowel disease: the ACTION study
Yehyun Park, Chang Hwan Choi, Hyun Soo Kim, Hee Seok Moon, Do Hyun Kim, Jin Ju Kim, Dennis Teng, Dong Il ParkYehyun Park, Chang Hwan Choi, Hyun Soo Kim, Hee Seok Moon, Do Hyun Kim, Jin Ju Kim, Dennis Teng, Dong Il Park
KMSID: 1516081550 Intest Res. 2022;20(4):452-463. Published online 2022 March 11 DOI: http://dx.doi.org/10.5217/ir.2021.00125 |
|
| 464 |
Long-term clinical and real-world experience with Crohn’s disease treated with anti-tumor necrosis factor-α antibodiesLong-term clinical and real-world experience with Crohn’s disease treated with anti-tumor necrosis factor-α antibodies
Haruka Otake, Satohiro Matsumoto, Hirosato MashimaHaruka Otake, Satohiro Matsumoto, Hirosato Mashima
KMSID: 1516081555 Intest Res. 2022;20(4):464-474. Published online 2022 March 31 DOI: http://dx.doi.org/10.5217/ir.2021.00139 |
|
| 475 |
Clinical features of very early-onset inflammatory bowel disease in Japan: a retrospective single-center studyClinical features of very early-onset inflammatory bowel disease in Japan: a retrospective single-center study
Masaaki Usami, Ichiro Takeuchi, Reiko Kyodo, Yuri Hirano, Kosuke Kashiwagi, Hiroki Fujikawa, Hirotaka Shimizu, Toshinao Kawai, Katsuhiro AraiMasaaki Usami, Ichiro Takeuchi, Reiko Kyodo, Yuri Hirano, Kosuke Kashiwagi, Hiroki Fujikawa, Hirotaka Shimizu, Toshinao Kawai, Katsuhiro Arai
KMSID: 1516081552 Intest Res. 2022;20(4):475-481. Published online 2022 June 13 DOI: http://dx.doi.org/10.5217/ir.2021.00142 |
|
| 482 |
Gastrointestinal bleeding risk of non-vitamin K antagonist oral anticoagulants versus warfarin in general and after polypectomy: a population-based study with propensity score matching analysisGastrointestinal bleeding risk of non-vitamin K antagonist oral anticoagulants versus warfarin in general and after polypectomy: a population-based study with propensity score matching analysis
Jong Yop Pae, Eun Soo Kim, Sung Kook Kim, Min Kyu Jung, Jun Heo, Jang Hoon Lee, Min Ae ParkJong Yop Pae, Eun Soo Kim, Sung Kook Kim, Min Kyu Jung, Jun Heo, Jang Hoon Lee, Min Ae Park
KMSID: 1516081556 Intest Res. 2022;20(4):482-494. Published online 2022 April 15 DOI: http://dx.doi.org/10.5217/ir.2021.00161 |
|
| 495 |
Abdominal aortic calcification in patients with inflammatory bowel disease: does anti-tumor necrosis factor α use protect from chronic inflammation-induced atherosclerosis?Abdominal aortic calcification in patients with inflammatory bowel disease: does anti-tumor necrosis factor α use protect from chronic inflammation-induced atherosclerosis?
Aikaterini Mantaka, Nikolaos Galanakis, Dimitrios Tsetis, Ioannis E. KoutroubakisAikaterini Mantaka, Nikolaos Galanakis, Dimitrios Tsetis, Ioannis E. Koutroubakis
KMSID: 1516081559 Intest Res. 2022;20(4):495-505. Published online 2022 August 8 DOI: http://dx.doi.org/10.5217/ir.2022.00017 |
|
| 506 |
Novel inflammatory bowel disease (IBD) specific electronic medical record allows scalable auditing of IBD severity, therapy and complications to show the current unmet need in IBD careNovel inflammatory bowel disease (IBD) specific electronic medical record allows scalable auditing of IBD severity, therapy and complications to show the current unmet need in IBD care
Alex Barnes, David Carter, Patricia Kaazan, Alissa Walsh, Susan Connor, Jane M AndrewsAlex Barnes, David Carter, Patricia Kaazan, Alissa Walsh, Susan Connor, Jane M Andrews
KMSID: 1516081558 Intest Res. 2022;20(4):506-508. Published online 2022 April 26 DOI: http://dx.doi.org/10.5217/ir.2022.00003 |
|
| 509 |
Urinary chitinase 3-like 1 and intestinal fatty-acid binding proteins are not elevated in children with inflammatory bowel diseaseUrinary chitinase 3-like 1 and intestinal fatty-acid binding proteins are not elevated in children with inflammatory bowel disease
Shaun Siong Chung Ho, Jacqueline Ilene Keenan, Andrew Stewart DayShaun Siong Chung Ho, Jacqueline Ilene Keenan, Andrew Stewart Day
KMSID: 1516081560 Intest Res. 2022;20(4):509-513. Published online 2022 July 22 DOI: http://dx.doi.org/10.5217/ir.2022.00064 |
|
